In Situ | GenomeWeb

In Situ

Fran DiNuzzo was part of a 10-member executive team that was working on combining Agilent Technologies’ genomics, proteomics, informatics, and bioreagents into a single business unit when Chris van Ingen, president and general manager of Agilent’s Life Sciences and Chemical Analysis unit, asked him to lead the Integrated Biology Solutions group.

“I jumped at the opportunity,” DiNuzzo told BioCommerce Week last week during a break from an analyst conference in Boston.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.